Searchable abstracts of presentations at key conferences in endocrinology

ea0049s12.1 | New development in Graves' Orbitopathy | ECE2017

The orbital fibroblast: a key player and target for therapy in graves’ orbitopathy

Dik Wim

GravesÂ’ orbitopathy (GO) is characterized by orbital tissue inflammation, expansion, remodelling and fibrosis. Although the initiating trigger of GO is still indistinct, excessive orbital fibroblast activity is at the heart of its pathogenesis. Orbital fibroblasts are activated by cellular interactions with immune cells and the soluble factors they secrete as well as autoantibodies (e.g. TSH-receptor autoantibodies). Activated orbital fibroblasts produce inflammatory medi...